Global and United States Recombinant Protein Drugs Market Report & Forecast 2022-2028

Global and United States Recombinant Protein Drugs Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Recombinant Protein Drugs Product Introduction
1.2 Global Recombinant Protein Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Recombinant Protein Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Recombinant Protein Drugs Sales in Volume for the Year 2017-2028
1.3 United States Recombinant Protein Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Recombinant Protein Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Recombinant Protein Drugs Sales in Volume for the Year 2017-2028
1.4 Recombinant Protein Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Recombinant Protein Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Recombinant Protein Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Recombinant Protein Drugs Market Dynamics
1.5.1 Recombinant Protein Drugs Industry Trends
1.5.2 Recombinant Protein Drugs Market Drivers
1.5.3 Recombinant Protein Drugs Market Challenges
1.5.4 Recombinant Protein Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Recombinant Protein Drugs Market Segment by Type
2.1.1 Recombinant DNA
2.1.2 Recombinant RNA
2.2 Global Recombinant Protein Drugs Market Size by Type
2.2.1 Global Recombinant Protein Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Recombinant Protein Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Recombinant Protein Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Recombinant Protein Drugs Market Size by Type
2.3.1 United States Recombinant Protein Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Recombinant Protein Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Recombinant Protein Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Recombinant Protein Drugs Market Segment by Application
3.1.1 Pharmaceutical Industry
3.1.2 Others
3.2 Global Recombinant Protein Drugs Market Size by Application
3.2.1 Global Recombinant Protein Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Recombinant Protein Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Recombinant Protein Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Recombinant Protein Drugs Market Size by Application
3.3.1 United States Recombinant Protein Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Recombinant Protein Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Recombinant Protein Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Recombinant Protein Drugs Competitor Landscape by Company
4.1 Global Recombinant Protein Drugs Market Size by Company
4.1.1 Top Global Recombinant Protein Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Recombinant Protein Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Recombinant Protein Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Recombinant Protein Drugs Price by Manufacturer (2017-2022)
4.2 Global Recombinant Protein Drugs Concentration Ratio (CR)
4.2.1 Recombinant Protein Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Recombinant Protein Drugs in 2021
4.2.3 Global Recombinant Protein Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Recombinant Protein Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Recombinant Protein Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Recombinant Protein Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Recombinant Protein Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Recombinant Protein Drugs Market Size by Company
4.5.1 Top Recombinant Protein Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Recombinant Protein Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Recombinant Protein Drugs Sales by Players (2020, 2021 & 2022)
5 Global Recombinant Protein Drugs Market Size by Region
5.1 Global Recombinant Protein Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Recombinant Protein Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Recombinant Protein Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Recombinant Protein Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Recombinant Protein Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Recombinant Protein Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Recombinant Protein Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Recombinant Protein Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Recombinant Protein Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Recombinant Protein Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Recombinant Protein Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Recombinant Protein Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Recombinant Protein Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Recombinant Protein Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Recombinant Protein Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Recombinant Protein Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Recombinant Protein Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Corporation Information
7.1.2 Novo Nordisk Description and Business Overview
7.1.3 Novo Nordisk Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Novo Nordisk Recombinant Protein Drugs Products Offered
7.1.5 Novo Nordisk Recent Development
7.2 Amgen
7.2.1 Amgen Corporation Information
7.2.2 Amgen Description and Business Overview
7.2.3 Amgen Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Amgen Recombinant Protein Drugs Products Offered
7.2.5 Amgen Recent Development
7.3 Sanofi
7.3.1 Sanofi Corporation Information
7.3.2 Sanofi Description and Business Overview
7.3.3 Sanofi Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Sanofi Recombinant Protein Drugs Products Offered
7.3.5 Sanofi Recent Development
7.4 Eli Lilly
7.4.1 Eli Lilly Corporation Information
7.4.2 Eli Lilly Description and Business Overview
7.4.3 Eli Lilly Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Eli Lilly Recombinant Protein Drugs Products Offered
7.4.5 Eli Lilly Recent Development
7.5 Merck Serono
7.5.1 Merck Serono Corporation Information
7.5.2 Merck Serono Description and Business Overview
7.5.3 Merck Serono Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Merck Serono Recombinant Protein Drugs Products Offered
7.5.5 Merck Serono Recent Development
7.6 Ortho Biotech
7.6.1 Ortho Biotech Corporation Information
7.6.2 Ortho Biotech Description and Business Overview
7.6.3 Ortho Biotech Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Ortho Biotech Recombinant Protein Drugs Products Offered
7.6.5 Ortho Biotech Recent Development
7.7 Roche
7.7.1 Roche Corporation Information
7.7.2 Roche Description and Business Overview
7.7.3 Roche Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Roche Recombinant Protein Drugs Products Offered
7.7.5 Roche Recent Development
7.8 Kyowa Hakko Kirin
7.8.1 Kyowa Hakko Kirin Corporation Information
7.8.2 Kyowa Hakko Kirin Description and Business Overview
7.8.3 Kyowa Hakko Kirin Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Kyowa Hakko Kirin Recombinant Protein Drugs Products Offered
7.8.5 Kyowa Hakko Kirin Recent Development
7.9 Pharmingen
7.9.1 Pharmingen Corporation Information
7.9.2 Pharmingen Description and Business Overview
7.9.3 Pharmingen Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Pharmingen Recombinant Protein Drugs Products Offered
7.9.5 Pharmingen Recent Development
7.10 Abcam
7.10.1 Abcam Corporation Information
7.10.2 Abcam Description and Business Overview
7.10.3 Abcam Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Abcam Recombinant Protein Drugs Products Offered
7.10.5 Abcam Recent Development
7.11 GenSci
7.11.1 GenSci Corporation Information
7.11.2 GenSci Description and Business Overview
7.11.3 GenSci Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 GenSci Recombinant Protein Drugs Products Offered
7.11.5 GenSci Recent Development
7.12 SL PHARM
7.12.1 SL PHARM Corporation Information
7.12.2 SL PHARM Description and Business Overview
7.12.3 SL PHARM Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 SL PHARM Products Offered
7.12.5 SL PHARM Recent Development
7.13 Dongbao Pharm
7.13.1 Dongbao Pharm Corporation Information
7.13.2 Dongbao Pharm Description and Business Overview
7.13.3 Dongbao Pharm Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Dongbao Pharm Products Offered
7.13.5 Dongbao Pharm Recent Development
7.14 Ankebio
7.14.1 Ankebio Corporation Information
7.14.2 Ankebio Description and Business Overview
7.14.3 Ankebio Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Ankebio Products Offered
7.14.5 Ankebio Recent Development
7.15 NCPC
7.15.1 NCPC Corporation Information
7.15.2 NCPC Description and Business Overview
7.15.3 NCPC Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.15.4 NCPC Products Offered
7.15.5 NCPC Recent Development
7.16 Heng Rui
7.16.1 Heng Rui Corporation Information
7.16.2 Heng Rui Description and Business Overview
7.16.3 Heng Rui Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Heng Rui Products Offered
7.16.5 Heng Rui Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Recombinant Protein Drugs Industry Chain Analysis
8.2 Recombinant Protein Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Recombinant Protein Drugs Distributors
8.3 Recombinant Protein Drugs Production Mode & Process
8.4 Recombinant Protein Drugs Sales and Marketing
8.4.1 Recombinant Protein Drugs Sales Channels
8.4.2 Recombinant Protein Drugs Distributors
8.5 Recombinant Protein Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Recombinant Protein Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Recombinant Protein Drugs Market Trends
Table 3. Recombinant Protein Drugs Market Drivers
Table 4. Recombinant Protein Drugs Market Challenges
Table 5. Recombinant Protein Drugs Market Restraints
Table 6. Global Recombinant Protein Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Recombinant Protein Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Recombinant Protein Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Recombinant Protein Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Recombinant Protein Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Recombinant Protein Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Recombinant Protein Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Recombinant Protein Drugs Sales by Manufacturer, (K Doses), 2017-2022
Table 14. Global Recombinant Protein Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Recombinant Protein Drugs Price by Manufacturer (2017-2022) & (USD/Dose)
Table 16. Global Recombinant Protein Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Recombinant Protein Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Protein Drugs as of 2021)
Table 18. Top Players of Recombinant Protein Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Recombinant Protein Drugs Product Type
Table 20. Date of International Manufacturers Enter into Recombinant Protein Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Recombinant Protein Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Recombinant Protein Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Recombinant Protein Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Recombinant Protein Drugs Sales by Players, (K Doses), 2020, 2021 & 2022
Table 26. United States Recombinant Protein Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Recombinant Protein Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Recombinant Protein Drugs Sales in Volume by Region (2017-2022) & (K Doses)
Table 29. Global Recombinant Protein Drugs Sales in Volume Forecast by Region (2023-2028) & (K Doses)
Table 30. Global Recombinant Protein Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Recombinant Protein Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Recombinant Protein Drugs Sales in Volume by Country (2017-2028) & (K Doses)
Table 33. North America Recombinant Protein Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Recombinant Protein Drugs Sales in Volume by Region (2017-2028) & (K Doses)
Table 35. Asia Pacific Recombinant Protein Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Recombinant Protein Drugs Sales in Volume by Country (2017-2028) & (K Doses)
Table 37. Europe Recombinant Protein Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Recombinant Protein Drugs Sales in Volume by Country (2017-2028) & (K Doses)
Table 39. Latin Americaa Recombinant Protein Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Recombinant Protein Drugs Sales in Volume by Country (2017-2028) & (K Doses)
Table 41. Middle East and Africa Recombinant Protein Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Novo Nordisk Corporation Information
Table 43. Novo Nordisk Description and Business Overview
Table 44. Novo Nordisk Recombinant Protein Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 45. Novo Nordisk Recombinant Protein Drugs Product
Table 46. Novo Nordisk Recent Development
Table 47. Amgen Corporation Information
Table 48. Amgen Description and Business Overview
Table 49. Amgen Recombinant Protein Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 50. Amgen Product
Table 51. Amgen Recent Development
Table 52. Sanofi Corporation Information
Table 53. Sanofi Description and Business Overview
Table 54. Sanofi Recombinant Protein Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 55. Sanofi Product
Table 56. Sanofi Recent Development
Table 57. Eli Lilly Corporation Information
Table 58. Eli Lilly Description and Business Overview
Table 59. Eli Lilly Recombinant Protein Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 60. Eli Lilly Product
Table 61. Eli Lilly Recent Development
Table 62. Merck Serono Corporation Information
Table 63. Merck Serono Description and Business Overview
Table 64. Merck Serono Recombinant Protein Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 65. Merck Serono Product
Table 66. Merck Serono Recent Development
Table 67. Ortho Biotech Corporation Information
Table 68. Ortho Biotech Description and Business Overview
Table 69. Ortho Biotech Recombinant Protein Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 70. Ortho Biotech Product
Table 71. Ortho Biotech Recent Development
Table 72. Roche Corporation Information
Table 73. Roche Description and Business Overview
Table 74. Roche Recombinant Protein Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 75. Roche Product
Table 76. Roche Recent Development
Table 77. Kyowa Hakko Kirin Corporation Information
Table 78. Kyowa Hakko Kirin Description and Business Overview
Table 79. Kyowa Hakko Kirin Recombinant Protein Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 80. Kyowa Hakko Kirin Product
Table 81. Kyowa Hakko Kirin Recent Development
Table 82. Pharmingen Corporation Information
Table 83. Pharmingen Description and Business Overview
Table 84. Pharmingen Recombinant Protein Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 85. Pharmingen Product
Table 86. Pharmingen Recent Development
Table 87. Abcam Corporation Information
Table 88. Abcam Description and Business Overview
Table 89. Abcam Recombinant Protein Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 90. Abcam Product
Table 91. Abcam Recent Development
Table 92. GenSci Corporation Information
Table 93. GenSci Description and Business Overview
Table 94. GenSci Recombinant Protein Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 95. GenSci Product
Table 96. GenSci Recent Development
Table 97. SL PHARM Corporation Information
Table 98. SL PHARM Description and Business Overview
Table 99. SL PHARM Recombinant Protein Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 100. SL PHARM Product
Table 101. SL PHARM Recent Development
Table 102. Dongbao Pharm Corporation Information
Table 103. Dongbao Pharm Description and Business Overview
Table 104. Dongbao Pharm Recombinant Protein Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 105. Dongbao Pharm Product
Table 106. Dongbao Pharm Recent Development
Table 107. Ankebio Corporation Information
Table 108. Ankebio Description and Business Overview
Table 109. Ankebio Recombinant Protein Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 110. Ankebio Product
Table 111. Ankebio Recent Development
Table 112. NCPC Corporation Information
Table 113. NCPC Description and Business Overview
Table 114. NCPC Recombinant Protein Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 115. NCPC Product
Table 116. NCPC Recent Development
Table 117. Heng Rui Corporation Information
Table 118. Heng Rui Description and Business Overview
Table 119. Heng Rui Recombinant Protein Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 120. Heng Rui Product
Table 121. Heng Rui Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Recombinant Protein Drugs Customers List
Table 125. Recombinant Protein Drugs Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Protein Drugs Product Picture
Figure 2. Global Recombinant Protein Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Recombinant Protein Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Recombinant Protein Drugs Sales 2017-2028 (K Doses)
Figure 5. United States Recombinant Protein Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Recombinant Protein Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Recombinant Protein Drugs Sales 2017-2028 (K Doses)
Figure 8. United States Recombinant Protein Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Recombinant Protein Drugs Market Share in Global, in Volume (K Doses) 2017-2028
Figure 10. Recombinant Protein Drugs Report Years Considered
Figure 11. Product Picture of Recombinant DNA
Figure 12. Product Picture of Recombinant RNA
Figure 13. Global Recombinant Protein Drugs Market Share by Type in 2022 & 2028
Figure 14. Global Recombinant Protein Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Recombinant Protein Drugs Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Recombinant Protein Drugs Sales by Type (2017-2028) & (K Doses)
Figure 17. Global Recombinant Protein Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Recombinant Protein Drugs Price by Type (2017-2028) & (USD/Dose)
Figure 19. United States Recombinant Protein Drugs Market Share by Type in 2022 & 2028
Figure 20. United States Recombinant Protein Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Recombinant Protein Drugs Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Recombinant Protein Drugs Sales by Type (2017-2028) & (K Doses)
Figure 23. United States Recombinant Protein Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Recombinant Protein Drugs Price by Type (2017-2028) & (USD/Dose)
Figure 25. Product Picture of Pharmaceutical Industry
Figure 26. Product Picture of Others
Figure 27. Global Recombinant Protein Drugs Market Share by Application in 2022 & 2028
Figure 28. Global Recombinant Protein Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 29. Global Recombinant Protein Drugs Sales Market Share in Value by Application (2017-2028)
Figure 30. Global Recombinant Protein Drugs Sales by Application (2017-2028) & (K Doses)
Figure 31. Global Recombinant Protein Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 32. Global Recombinant Protein Drugs Price by Application (2017-2028) & (USD/Dose)
Figure 33. United States Recombinant Protein Drugs Market Share by Application in 2022 & 2028
Figure 34. United States Recombinant Protein Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 35. United States Recombinant Protein Drugs Sales Market Share in Value by Application (2017-2028)
Figure 36. United States Recombinant Protein Drugs Sales by Application (2017-2028) & (K Doses)
Figure 37. United States Recombinant Protein Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 38. United States Recombinant Protein Drugs Price by Application (2017-2028) & (USD/Dose)
Figure 39. North America Recombinant Protein Drugs Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 40. North America Recombinant Protein Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 41. U.S. Recombinant Protein Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 42. Canada Recombinant Protein Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Europe Recombinant Protein Drugs Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 44. Europe Recombinant Protein Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 45. Germany Recombinant Protein Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. France Recombinant Protein Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. U.K. Recombinant Protein Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. Italy Recombinant Protein Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Russia Recombinant Protein Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Asia-Pacific Recombinant Protein Drugs Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 51. Asia-Pacific Recombinant Protein Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 52. China Recombinant Protein Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Japan Recombinant Protein Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. South Korea Recombinant Protein Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. India Recombinant Protein Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Australia Recombinant Protein Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Taiwan Recombinant Protein Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Indonesia Recombinant Protein Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Thailand Recombinant Protein Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Malaysia Recombinant Protein Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Philippines Recombinant Protein Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Latin America Recombinant Protein Drugs Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 63. Latin America Recombinant Protein Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 64. Mexico Recombinant Protein Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Brazil Recombinant Protein Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Argentina Recombinant Protein Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Middle East & Africa Recombinant Protein Drugs Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 68. Middle East & Africa Recombinant Protein Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 69. Turkey Recombinant Protein Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Saudi Arabia Recombinant Protein Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. U.A.E Recombinant Protein Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Recombinant Protein Drugs Value Chain
Figure 73. Recombinant Protein Drugs Production Process
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs